Can-Fite Announces Eurasian Patent Allowance for Piclidenoson
The allowed claims cover Lowe syndrome and Dent disease 2. Can-Fite holds development, commercialization and out-licensing rights for these indications under an agreement with Fondazione Telethon.
Story updates
12:09:49 PM UTC
SquawkNews
The Eurasian Patent Office issued a notification of readiness to grant a patent covering Piclidenoson for OCRL-deficiency diseases, including Lowe syndrome and Dent disease 2. Can-Fite holds development, commercialization and out-licensing rights for Lowe syndrome; grant formalities remain.Material…